Session Title: Quick Fire Free Paper 5
Session Date/Time: Sunday 14/09/2014 | 11:00-13:00
Paper Time: 11:35
Venue: Boulevard B
First Author: : K.H.Madan INDIA
Co Author(s): : S. Mittal
To present a case series of 12 patients of chronic Central Serous Chorio-retinopathy treated with intra-vitreal Bevacizumab.
Interventional Case Series.
Twelve consecutive patients of chronic Central Serous Chorio-retinopathy (CSR) were treated with intravitreal injection of 2.5 mg Bevacizumab at 4 week intervals for 3 months. Diagnosis of chronic Central Serous Chorio-retinopathy was made on the basis of duration of disease (more than 9 months). It was confirmed by Fundus Examination, Optical Coherence Tomography (OCT) and Fundus Fluorescein Angiography (FFA). Best Corrected Visual Acuity (BCVA), Fundus Examination, Optical Coherence Tomography (OCT) were performed at every 4 week intervals.
More than 2 lines of improvement in visual acuity was seen in 9 (75%) eyes. Complete resolution of sub retinal fluid was seen in 10 out of 12 eyes (83%).
Intra-vitreal Bevacizumab can be a treatment option in patients of chronic Central Serous Chorio-retinopathy.